| Fonds | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 16.450.747 $ | +8.661.316 $ | +111,2 % | 132.486.066 $ | +43.227.279 $ | +7.508,6 % | 101.649.640 $ | +5.558.226 $ | +73,0 % | 71.935.882 $ | +20.306.808 $ | +43,2 % | |
| MORGAN STANLEY | 23.860.411 $ | +6.705.437 $ | +39,1 % | 17.154.974 $ | +6.117.063 $ | +55,4 % | 11.037.911 $ | +4.239.422 $ | +62,4 % | |||
| RA CAPITAL MANAGEMENT, L.P. | 21.040.000 $ | +5.760.000 $ | +37,7 % | 15.280.000 $ | ||||||||
| Bain Capital Life Sciences Investors, LLC | 18.862.123 $ | +5.163.775 $ | +37,7 % | 13.698.348 $ | +11.229.908 $ | +454,9 % | ||||||
| Lynx1 Capital Management LP | 18.407.112 $ | +4.849.678 $ | +35,8 % | 13.557.434 $ | -2.200.421 $ | -14,0 % | 15.757.855 $ | +5.607.525 $ | +55,2 % | |||
| Point72 Asset Management, L.P. | 18.029.116 $ | |||||||||||
| WASATCH ADVISORS LP | 16.450.747 $ | +8.661.316 $ | +111,2 % | 7.789.431 $ | -509.362 $ | -6,1 % | 8.298.793 $ | -2.474.292 $ | -23,0 % | 10.773.085 $ | +155.818 $ | +1,5 % |
| Soleus Capital Management, L.P. | 10.004.367 $ | +2.738.838 $ | +37,7 % | 7.265.529 $ | -8.394.222 $ | -53,6 % | 15.659.751 $ | +5.679.864 $ | +56,9 % | |||
| ORBIMED ADVISORS LLC | 11.622.024 $ | +1.854.695 $ | +19,0 % | |||||||||
| VANGUARD CAPITAL MANAGEMENT LLC | 10.156.671 $ | |||||||||||
| VANGUARD GROUP INC | 8.365.446 $ | +1.280.190 $ | +18,1 % | 7.085.256 $ | +2.769.484 $ | +64,2 % | ||||||
| TWO SIGMA INVESTMENTS, LP | 7.983.717 $ | +5.100.375 $ | +176,9 % | |||||||||
| JPMORGAN CHASE & CO | 7.574.177 $ | +7.562.822 $ | +66.603,5 % | |||||||||
| CITADEL ADVISORS LLC | 6.808.057 $ | +5.855.716 $ | +614,9 % | |||||||||
| 16.450.747 $ | +8.661.316 $ | +111,2 % | 132.486.066 $ | +43.227.279 $ | +7.508,6 % | 101.649.640 $ | +5.558.226 $ | +73,0 % | 71.935.882 $ | +20.306.808 $ | +43,2 % | |